These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8690755)

  • 1. Differential expression of jackfruit-lectin-specific glycoconjugates in metastatic adenocarcinoma and reactive mesothelial cells-a diagnostic aid in effusion cytology.
    Sujathan K; Kannan S; Remani P; Pillai KR; Chandralekha B; Amma NS; Nair MK
    J Cancer Res Clin Oncol; 1996; 122(7):433-6. PubMed ID: 8690755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small orangiophilic squamous-like cells: an underrecognized and useful morphological feature for the diagnosis of malignant mesothelioma in pleural effusion cytology.
    Chen L; Caldero SG; Gmitro S; Smith ML; De Petris G; Zarka MA
    Cancer Cytopathol; 2014 Jan; 122(1):70-5. PubMed ID: 23983174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of a galactose specific plant lectin for the differential diagnosis of adenocarcinoma cells in effusion.
    Sujathan K; Jayasree K; Remani P
    J Cytol; 2009 Oct; 26(4):134-9. PubMed ID: 21938176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IMP3/L523S, a novel immunocytochemical marker that distinguishes benign and malignant cells: the expression profiles of IMP3/L523S in effusion cytology.
    Ikeda K; Tate G; Suzuki T; Kitamura T; Mitsuya T
    Hum Pathol; 2010 May; 41(5):745-50. PubMed ID: 20060157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry.
    Su XY; Li GD; Liu WP; Xie B; Jiang YH
    Diagn Cytopathol; 2011 Dec; 39(12):900-8. PubMed ID: 20836004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic usefulness of EMA, IMP3, and GLUT-1 for the immunocytochemical distinction of malignant cells from reactive mesothelial cells in effusion cytology using cytospin preparations.
    Ikeda K; Tate G; Suzuki T; Kitamura T; Mitsuya T
    Diagn Cytopathol; 2011 Jun; 39(6):395-401. PubMed ID: 21574259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic utility of GLUT-1 expression in the cytologic evaluation of serous fluids.
    Afify A; Zhou H; Howell L; Paulino AF
    Acta Cytol; 2005; 49(6):621-6. PubMed ID: 16450901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of mesothelioma from adenocarcinoma in serous effusions: the role of hyaluronic acid and CD44 localization.
    Afify AM; Stern R; Michael CW
    Diagn Cytopathol; 2005 Mar; 32(3):145-50. PubMed ID: 15690337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of p53 and ki67 immunostaining for distinguishing benign from malignant serous effusions.
    Hafez NH; Tahoun NS
    J Egypt Natl Canc Inst; 2011 Dec; 23(4):155-62. PubMed ID: 22776843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinguishing benign from malignant pleural effusions by lectin immunocytochemistry.
    Rosen-Levin E; Patil JR; Watson CW; Jagirdar J
    Acta Cytol; 1989; 33(4):499-504. PubMed ID: 2473586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of CD44s and CD44v3-10 in adenocarcinoma cells and reactive mesothelial cells in effusions.
    Berner HS; Davidson B; Berner A; Risberg B; Nesland JM
    Virchows Arch; 2000 Apr; 436(4):330-5. PubMed ID: 10834535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids.
    Politi E; Kandaraki C; Apostolopoulou C; Kyritsi T; Koutselini H
    Diagn Cytopathol; 2005 Mar; 32(3):151-5. PubMed ID: 15690338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of anti-L523S antibody in the diagnosis of benign and malignant serous effusions.
    Hanley KZ; Facik MS; Bourne PA; Yang Q; Spaulding BO; Bonfiglio TA; Xu H
    Cancer; 2008 Feb; 114(1):49-56. PubMed ID: 18098206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D2-40 is not a specific marker for cells of mesothelial origin in serous effusions.
    Bassarova AV; Nesland JM; Davidson B
    Am J Surg Pathol; 2006 Jul; 30(7):878-82. PubMed ID: 16819331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of AgNOR count in differentiating malignant cells from reactive mesothelial cells in serous effusions.
    Sujathan K; Kannan S; Pillai KR; Chandralekha B; Amma NS; Nair MK
    Acta Cytol; 1996; 40(4):724-8. PubMed ID: 8693893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lectin binding properties of cells from serous effusion and peritoneal washing specimens.
    Shield PW
    J Clin Pathol; 1989 Nov; 42(11):1178-83. PubMed ID: 2479665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytological study of serous effusions with the aid of tumour markers.
    Ray K; Mittal S; Gupta H; Jain M
    J Indian Med Assoc; 1999 Jan; 97(1):11-2, 19. PubMed ID: 10549179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenocarcinoma cells in effusion cytology as a diagnostic pitfall with potential impact on clinical management: a case report with brief review of immunomarkers.
    Chowdhuri SR; Fetsch P; Squires J; Kohn E; Filie AC
    Diagn Cytopathol; 2014 Mar; 42(3):253-8. PubMed ID: 23161830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimens.
    Shield PW; Papadimos DJ; Walsh MD
    Cancer Cytopathol; 2014 Apr; 122(4):307-12. PubMed ID: 24421220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A panel of markers for identification of malignant and non-malignant cells in culture from effusions.
    Carneiro FP; Muniz-Junqueira MI; Pittella-Silva F; Carneiro MV; Takano GHS; Vianna LMS; De Andrade LB; De Castro TMML; Peres I; Dos Santos Borges TK; Ferreira VM; Motoyama AB
    Oncol Rep; 2017 Dec; 38(6):3538-3544. PubMed ID: 29039588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.